nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—AGTR1—dilated cardiomyopathy	0.582	1	CbGaD
Olmesartan—ABCC2—Spironolactone—dilated cardiomyopathy	0.166	0.594	CbGbCtD
Olmesartan—ABCC2—Furosemide—dilated cardiomyopathy	0.114	0.406	CbGbCtD
Olmesartan—Angiitis necrotising—Furosemide—dilated cardiomyopathy	0.00452	0.0423	CcSEcCtD
Olmesartan—Xanthopsia—Furosemide—dilated cardiomyopathy	0.00452	0.0423	CcSEcCtD
Olmesartan—Vasculitis necrotising—Furosemide—dilated cardiomyopathy	0.00394	0.0368	CcSEcCtD
Olmesartan—AGTR1—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.00366	0.152	CbGpPWpGaD
Olmesartan—AGTR1—ACE Inhibitor Pathway—NR3C2—dilated cardiomyopathy	0.00285	0.118	CbGpPWpGaD
Olmesartan—Hypovolaemia—Furosemide—dilated cardiomyopathy	0.00266	0.0249	CcSEcCtD
Olmesartan—Gastric irritation—Furosemide—dilated cardiomyopathy	0.00213	0.0199	CcSEcCtD
Olmesartan—Tasosartan—AGTR2—dilated cardiomyopathy	0.0019	0.263	CrCbGaD
Olmesartan—Diabetic—Lisinopril—dilated cardiomyopathy	0.00186	0.0174	CcSEcCtD
Olmesartan—Epigastric discomfort—Furosemide—dilated cardiomyopathy	0.00157	0.0147	CcSEcCtD
Olmesartan—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00155	0.0145	CcSEcCtD
Olmesartan—AGTR1—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.00154	0.0639	CbGpPWpGaD
Olmesartan—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.00149	0.0139	CcSEcCtD
Olmesartan—AGTR1—ACE Inhibitor Pathway—ACE—dilated cardiomyopathy	0.00131	0.0545	CbGpPWpGaD
Olmesartan—Blood triglycerides increased—Furosemide—dilated cardiomyopathy	0.00126	0.0118	CcSEcCtD
Olmesartan—Appetite absent—Lisinopril—dilated cardiomyopathy	0.00124	0.0116	CcSEcCtD
Olmesartan—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.00122	0.0114	CcSEcCtD
Olmesartan—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00119	0.0112	CcSEcCtD
Olmesartan—Azilsartan medoxomil—AGTR1—dilated cardiomyopathy	0.00117	0.162	CrCbGaD
Olmesartan—Lethargy—Spironolactone—dilated cardiomyopathy	0.00112	0.0105	CcSEcCtD
Olmesartan—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.0011	0.0103	CcSEcCtD
Olmesartan—Forasartan—AGTR1—dilated cardiomyopathy	0.00109	0.15	CrCbGaD
Olmesartan—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.00108	0.0101	CcSEcCtD
Olmesartan—Glycosuria—Furosemide—dilated cardiomyopathy	0.00102	0.00953	CcSEcCtD
Olmesartan—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.000992	0.00927	CcSEcCtD
Olmesartan—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.000942	0.00881	CcSEcCtD
Olmesartan—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.000939	0.00879	CcSEcCtD
Olmesartan—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.000917	0.00858	CcSEcCtD
Olmesartan—ABCC2—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000907	0.0377	CbGpPWpGaD
Olmesartan—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00089	0.00832	CcSEcCtD
Olmesartan—Gout—Furosemide—dilated cardiomyopathy	0.000884	0.00827	CcSEcCtD
Olmesartan—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.000877	0.0082	CcSEcCtD
Olmesartan—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.000867	0.00811	CcSEcCtD
Olmesartan—Hyperlipidaemia—Lisinopril—dilated cardiomyopathy	0.000859	0.00804	CcSEcCtD
Olmesartan—Vasculitis—Furosemide—dilated cardiomyopathy	0.000846	0.00791	CcSEcCtD
Olmesartan—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00084	0.00786	CcSEcCtD
Olmesartan—Renal failure—Spironolactone—dilated cardiomyopathy	0.000834	0.0078	CcSEcCtD
Olmesartan—AGTR1—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.000832	0.0346	CbGpPWpGaD
Olmesartan—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000792	0.00741	CcSEcCtD
Olmesartan—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.000775	0.00725	CcSEcCtD
Olmesartan—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.000764	0.00715	CcSEcCtD
Olmesartan—Lightheadedness—Furosemide—dilated cardiomyopathy	0.000738	0.00691	CcSEcCtD
Olmesartan—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.000705	0.00659	CcSEcCtD
Olmesartan—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.000689	0.00644	CcSEcCtD
Olmesartan—Viral infection—Lisinopril—dilated cardiomyopathy	0.000686	0.00641	CcSEcCtD
Olmesartan—Alopecia—Spironolactone—dilated cardiomyopathy	0.000673	0.0063	CcSEcCtD
Olmesartan—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.000664	0.00621	CcSEcCtD
Olmesartan—Gout—Lisinopril—dilated cardiomyopathy	0.000663	0.0062	CcSEcCtD
Olmesartan—Tasosartan—AGTR1—dilated cardiomyopathy	0.000659	0.0911	CrCbGaD
Olmesartan—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000638	0.00596	CcSEcCtD
Olmesartan—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000634	0.00593	CcSEcCtD
Olmesartan—AGTR1—Arf6 signaling events—ADRB2—dilated cardiomyopathy	0.000629	0.0262	CbGpPWpGaD
Olmesartan—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000615	0.00575	CcSEcCtD
Olmesartan—Lethargy—Furosemide—dilated cardiomyopathy	0.000611	0.00572	CcSEcCtD
Olmesartan—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.000608	0.00569	CcSEcCtD
Olmesartan—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000601	0.00563	CcSEcCtD
Olmesartan—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.000601	0.00562	CcSEcCtD
Olmesartan—Malaise—Spironolactone—dilated cardiomyopathy	0.000598	0.00559	CcSEcCtD
Olmesartan—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000594	0.00555	CcSEcCtD
Olmesartan—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.000585	0.00547	CcSEcCtD
Olmesartan—Valsartan—AGTR1—dilated cardiomyopathy	0.000572	0.079	CrCbGaD
Olmesartan—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000561	0.00525	CcSEcCtD
Olmesartan—Discomfort—Spironolactone—dilated cardiomyopathy	0.000558	0.00522	CcSEcCtD
Olmesartan—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.000554	0.00518	CcSEcCtD
Olmesartan—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000547	0.00512	CcSEcCtD
Olmesartan—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000545	0.0051	CcSEcCtD
Olmesartan—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000541	0.00506	CcSEcCtD
Olmesartan—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000539	0.00505	CcSEcCtD
Olmesartan—Telmisartan—AGTR1—dilated cardiomyopathy	0.000537	0.0743	CrCbGaD
Olmesartan—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00053	0.00496	CcSEcCtD
Olmesartan—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.000519	0.00486	CcSEcCtD
Olmesartan—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000517	0.00483	CcSEcCtD
Olmesartan—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000513	0.00479	CcSEcCtD
Olmesartan—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000508	0.00475	CcSEcCtD
Olmesartan—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.000507	0.00474	CcSEcCtD
Olmesartan—Eczema—Lisinopril—dilated cardiomyopathy	0.0005	0.00468	CcSEcCtD
Olmesartan—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000498	0.00466	CcSEcCtD
Olmesartan—AGTR1—Arf6 trafficking events—ADRB2—dilated cardiomyopathy	0.000497	0.0207	CbGpPWpGaD
Olmesartan—Injury—Lisinopril—dilated cardiomyopathy	0.000489	0.00457	CcSEcCtD
Olmesartan—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000487	0.00455	CcSEcCtD
Olmesartan—AGTR1—Arf6 trafficking events—ITGB1—dilated cardiomyopathy	0.00048	0.02	CbGpPWpGaD
Olmesartan—AGTR1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.000474	0.0197	CbGpPWpGaD
Olmesartan—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000473	0.00442	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000467	0.00437	CcSEcCtD
Olmesartan—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000467	0.00437	CcSEcCtD
Olmesartan—Arthritis—Lisinopril—dilated cardiomyopathy	0.000462	0.00433	CcSEcCtD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—ITGB1—dilated cardiomyopathy	0.000457	0.019	CbGpPWpGaD
Olmesartan—Renal failure—Furosemide—dilated cardiomyopathy	0.000454	0.00424	CcSEcCtD
Olmesartan—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000451	0.00422	CcSEcCtD
Olmesartan—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.000449	0.0042	CcSEcCtD
Olmesartan—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000446	0.00417	CcSEcCtD
Olmesartan—AGTR1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.000441	0.0183	CbGpPWpGaD
Olmesartan—Face oedema—Lisinopril—dilated cardiomyopathy	0.000434	0.00406	CcSEcCtD
Olmesartan—Candesartan—AGTR1—dilated cardiomyopathy	0.000433	0.0599	CrCbGaD
Olmesartan—Irbesartan—AGTR1—dilated cardiomyopathy	0.000433	0.0599	CrCbGaD
Olmesartan—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000431	0.00403	CcSEcCtD
Olmesartan—Urticaria—Spironolactone—dilated cardiomyopathy	0.00043	0.00402	CcSEcCtD
Olmesartan—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000428	0.004	CcSEcCtD
Olmesartan—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000421	0.00394	CcSEcCtD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000416	0.0173	CbGpPWpGaD
Olmesartan—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000411	0.00384	CcSEcCtD
Olmesartan—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000409	0.00383	CcSEcCtD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RPS6KB1—dilated cardiomyopathy	0.000407	0.0169	CbGpPWpGaD
Olmesartan—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000406	0.0038	CcSEcCtD
Olmesartan—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000405	0.00379	CcSEcCtD
Olmesartan—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000402	0.00376	CcSEcCtD
Olmesartan—Influenza—Lisinopril—dilated cardiomyopathy	0.000388	0.00363	CcSEcCtD
Olmesartan—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000385	0.0036	CcSEcCtD
Olmesartan—Pruritus—Spironolactone—dilated cardiomyopathy	0.000383	0.00358	CcSEcCtD
Olmesartan—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000381	0.00356	CcSEcCtD
Olmesartan—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000378	0.00354	CcSEcCtD
Olmesartan—Angiopathy—Furosemide—dilated cardiomyopathy	0.000376	0.00352	CcSEcCtD
Olmesartan—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000374	0.00349	CcSEcCtD
Olmesartan—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00037	0.00346	CcSEcCtD
Olmesartan—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00037	0.00346	CcSEcCtD
Olmesartan—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000369	0.00345	CcSEcCtD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RAC1—dilated cardiomyopathy	0.000367	0.0153	CbGpPWpGaD
Olmesartan—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000363	0.0034	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000361	0.00338	CcSEcCtD
Olmesartan—Malnutrition—Furosemide—dilated cardiomyopathy	0.000361	0.00337	CcSEcCtD
Olmesartan—Dizziness—Spironolactone—dilated cardiomyopathy	0.000358	0.00335	CcSEcCtD
Olmesartan—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000358	0.00335	CcSEcCtD
Olmesartan—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000355	0.00332	CcSEcCtD
Olmesartan—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00035	0.00328	CcSEcCtD
Olmesartan—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000348	0.00326	CcSEcCtD
Olmesartan—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000347	0.00324	CcSEcCtD
Olmesartan—Vomiting—Spironolactone—dilated cardiomyopathy	0.000344	0.00322	CcSEcCtD
Olmesartan—Rash—Spironolactone—dilated cardiomyopathy	0.000341	0.00319	CcSEcCtD
Olmesartan—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000341	0.00319	CcSEcCtD
Olmesartan—Renal failure—Lisinopril—dilated cardiomyopathy	0.00034	0.00318	CcSEcCtD
Olmesartan—Vision blurred—Furosemide—dilated cardiomyopathy	0.00034	0.00318	CcSEcCtD
Olmesartan—Headache—Spironolactone—dilated cardiomyopathy	0.000339	0.00317	CcSEcCtD
Olmesartan—Jaundice—Lisinopril—dilated cardiomyopathy	0.000338	0.00316	CcSEcCtD
Olmesartan—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000337	0.00315	CcSEcCtD
Olmesartan—Anaemia—Furosemide—dilated cardiomyopathy	0.000333	0.00312	CcSEcCtD
Olmesartan—Agitation—Furosemide—dilated cardiomyopathy	0.000332	0.0031	CcSEcCtD
Olmesartan—Haematuria—Lisinopril—dilated cardiomyopathy	0.00033	0.00309	CcSEcCtD
Olmesartan—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000325	0.00304	CcSEcCtD
Olmesartan—Vertigo—Furosemide—dilated cardiomyopathy	0.000324	0.00303	CcSEcCtD
Olmesartan—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000323	0.00302	CcSEcCtD
Olmesartan—Leukopenia—Furosemide—dilated cardiomyopathy	0.000323	0.00302	CcSEcCtD
Olmesartan—Nausea—Spironolactone—dilated cardiomyopathy	0.000321	0.00301	CcSEcCtD
Olmesartan—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000312	0.00292	CcSEcCtD
Olmesartan—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000309	0.00289	CcSEcCtD
Olmesartan—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000307	0.00287	CcSEcCtD
Olmesartan—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000306	0.00287	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000305	0.00285	CcSEcCtD
Olmesartan—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000305	0.00285	CcSEcCtD
Olmesartan—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000294	0.00275	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—IL10—dilated cardiomyopathy	0.00029	0.012	CbGpPWpGaD
Olmesartan—Shock—Furosemide—dilated cardiomyopathy	0.00029	0.00271	CcSEcCtD
Olmesartan—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000289	0.0027	CcSEcCtD
Olmesartan—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000288	0.0027	CcSEcCtD
Olmesartan—Skin disorder—Furosemide—dilated cardiomyopathy	0.000286	0.00268	CcSEcCtD
Olmesartan—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000285	0.00266	CcSEcCtD
Olmesartan—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000282	0.00264	CcSEcCtD
Olmesartan—Anorexia—Furosemide—dilated cardiomyopathy	0.000281	0.00263	CcSEcCtD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00028	0.0116	CbGpPWpGaD
Olmesartan—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00028	0.00262	CcSEcCtD
Olmesartan—Losartan—AGTR1—dilated cardiomyopathy	0.000279	0.0386	CrCbGaD
Olmesartan—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000278	0.0026	CcSEcCtD
Olmesartan—Hypotension—Furosemide—dilated cardiomyopathy	0.000275	0.00257	CcSEcCtD
Olmesartan—Alopecia—Lisinopril—dilated cardiomyopathy	0.000275	0.00257	CcSEcCtD
Olmesartan—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000272	0.00255	CcSEcCtD
Olmesartan—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000271	0.00253	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000269	0.0112	CbGpPWpGaD
Olmesartan—Back pain—Lisinopril—dilated cardiomyopathy	0.000262	0.00245	CcSEcCtD
Olmesartan—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00026	0.00243	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—FAS—dilated cardiomyopathy	0.00026	0.0108	CbGpPWpGaD
Olmesartan—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000256	0.00239	CcSEcCtD
Olmesartan—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000255	0.00239	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000254	0.00238	CcSEcCtD
Olmesartan—Fatigue—Furosemide—dilated cardiomyopathy	0.000254	0.00237	CcSEcCtD
Olmesartan—Constipation—Furosemide—dilated cardiomyopathy	0.000252	0.00236	CcSEcCtD
Olmesartan—Pain—Furosemide—dilated cardiomyopathy	0.000252	0.00236	CcSEcCtD
Olmesartan—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000251	0.00235	CcSEcCtD
Olmesartan—Anaemia—Lisinopril—dilated cardiomyopathy	0.00025	0.00234	CcSEcCtD
Olmesartan—Angioedema—Lisinopril—dilated cardiomyopathy	0.000247	0.00231	CcSEcCtD
Olmesartan—Malaise—Lisinopril—dilated cardiomyopathy	0.000244	0.00228	CcSEcCtD
Olmesartan—Vertigo—Lisinopril—dilated cardiomyopathy	0.000243	0.00227	CcSEcCtD
Olmesartan—Syncope—Lisinopril—dilated cardiomyopathy	0.000243	0.00227	CcSEcCtD
Olmesartan—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000243	0.00227	CcSEcCtD
Olmesartan—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000242	0.00227	CcSEcCtD
Olmesartan—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000241	0.00225	CcSEcCtD
Olmesartan—Palpitations—Lisinopril—dilated cardiomyopathy	0.000239	0.00224	CcSEcCtD
Olmesartan—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000238	0.00223	CcSEcCtD
Olmesartan—Cough—Lisinopril—dilated cardiomyopathy	0.000236	0.00221	CcSEcCtD
Olmesartan—Urticaria—Furosemide—dilated cardiomyopathy	0.000234	0.00219	CcSEcCtD
Olmesartan—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000233	0.00218	CcSEcCtD
Olmesartan—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000233	0.00218	CcSEcCtD
Olmesartan—Chest pain—Lisinopril—dilated cardiomyopathy	0.00023	0.00216	CcSEcCtD
Olmesartan—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00023	0.00216	CcSEcCtD
Olmesartan—Myalgia—Lisinopril—dilated cardiomyopathy	0.00023	0.00216	CcSEcCtD
Olmesartan—Anxiety—Lisinopril—dilated cardiomyopathy	0.00023	0.00215	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000229	0.00214	CcSEcCtD
Olmesartan—Discomfort—Lisinopril—dilated cardiomyopathy	0.000228	0.00213	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.000223	0.00926	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.000223	0.00926	CbGpPWpGaD
Olmesartan—AGTR1—Arf6 signaling events—EGFR—dilated cardiomyopathy	0.000222	0.00923	CbGpPWpGaD
Olmesartan—Oedema—Lisinopril—dilated cardiomyopathy	0.000221	0.00207	CcSEcCtD
Olmesartan—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000221	0.00207	CcSEcCtD
Olmesartan—Infection—Lisinopril—dilated cardiomyopathy	0.000219	0.00205	CcSEcCtD
Olmesartan—Shock—Lisinopril—dilated cardiomyopathy	0.000217	0.00203	CcSEcCtD
Olmesartan—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000216	0.00202	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000216	0.00898	CbGpPWpGaD
Olmesartan—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000216	0.00202	CcSEcCtD
Olmesartan—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000215	0.00201	CcSEcCtD
Olmesartan—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000214	0.002	CcSEcCtD
Olmesartan—Asthenia—Furosemide—dilated cardiomyopathy	0.000211	0.00198	CcSEcCtD
Olmesartan—Anorexia—Lisinopril—dilated cardiomyopathy	0.000211	0.00197	CcSEcCtD
Olmesartan—Pruritus—Furosemide—dilated cardiomyopathy	0.000208	0.00195	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000207	0.00861	CbGpPWpGaD
Olmesartan—Hypotension—Lisinopril—dilated cardiomyopathy	0.000206	0.00193	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000203	0.00844	CbGpPWpGaD
Olmesartan—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000201	0.00188	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000201	0.00188	CcSEcCtD
Olmesartan—Insomnia—Lisinopril—dilated cardiomyopathy	0.0002	0.00187	CcSEcCtD
Olmesartan—Dizziness—Furosemide—dilated cardiomyopathy	0.000195	0.00182	CcSEcCtD
Olmesartan—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000194	0.00182	CcSEcCtD
Olmesartan—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000192	0.0018	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000191	0.00178	CcSEcCtD
Olmesartan—Fatigue—Lisinopril—dilated cardiomyopathy	0.00019	0.00178	CcSEcCtD
Olmesartan—Pain—Lisinopril—dilated cardiomyopathy	0.000189	0.00177	CcSEcCtD
Olmesartan—Constipation—Lisinopril—dilated cardiomyopathy	0.000189	0.00177	CcSEcCtD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000188	0.00783	CbGpPWpGaD
Olmesartan—Vomiting—Furosemide—dilated cardiomyopathy	0.000187	0.00175	CcSEcCtD
Olmesartan—Rash—Furosemide—dilated cardiomyopathy	0.000186	0.00174	CcSEcCtD
Olmesartan—Dermatitis—Furosemide—dilated cardiomyopathy	0.000185	0.00173	CcSEcCtD
Olmesartan—Headache—Furosemide—dilated cardiomyopathy	0.000184	0.00173	CcSEcCtD
Olmesartan—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000182	0.0017	CcSEcCtD
Olmesartan—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000181	0.00169	CcSEcCtD
Olmesartan—Urticaria—Lisinopril—dilated cardiomyopathy	0.000176	0.00164	CcSEcCtD
Olmesartan—Nausea—Furosemide—dilated cardiomyopathy	0.000175	0.00164	CcSEcCtD
Olmesartan—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000175	0.00163	CcSEcCtD
Olmesartan—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000175	0.00163	CcSEcCtD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000175	0.00725	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000162	0.00674	CbGpPWpGaD
Olmesartan—Losartan—ACE—dilated cardiomyopathy	0.000161	0.0223	CrCbGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—dilated cardiomyopathy	0.000159	0.00661	CbGpPWpGaD
Olmesartan—Asthenia—Lisinopril—dilated cardiomyopathy	0.000159	0.00148	CcSEcCtD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000157	0.00653	CbGpPWpGaD
Olmesartan—Pruritus—Lisinopril—dilated cardiomyopathy	0.000156	0.00146	CcSEcCtD
Olmesartan—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000151	0.00141	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00015	0.00621	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00015	0.00621	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000146	0.00608	CbGpPWpGaD
Olmesartan—Dizziness—Lisinopril—dilated cardiomyopathy	0.000146	0.00137	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000145	0.00603	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000142	0.00592	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000142	0.00592	CbGpPWpGaD
Olmesartan—Vomiting—Lisinopril—dilated cardiomyopathy	0.00014	0.00131	CcSEcCtD
Olmesartan—Rash—Lisinopril—dilated cardiomyopathy	0.000139	0.0013	CcSEcCtD
Olmesartan—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000139	0.0013	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000139	0.00578	CbGpPWpGaD
Olmesartan—Headache—Lisinopril—dilated cardiomyopathy	0.000138	0.00129	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000137	0.00567	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000135	0.00559	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000132	0.0055	CbGpPWpGaD
Olmesartan—Nausea—Lisinopril—dilated cardiomyopathy	0.000131	0.00123	CcSEcCtD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000127	0.00529	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000122	0.00508	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000121	0.00501	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000114	0.00473	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000114	0.00473	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—TNF—dilated cardiomyopathy	0.00011	0.00458	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000109	0.00454	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000109	0.00453	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000106	0.0044	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000105	0.00435	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000103	0.00426	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000102	0.00423	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000102	0.00423	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	9.84e-05	0.00409	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ANKRD1—dilated cardiomyopathy	9.62e-05	0.004	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	9.57e-05	0.00398	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	9.57e-05	0.00398	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	9.47e-05	0.00394	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—TAZ—dilated cardiomyopathy	9.05e-05	0.00376	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	8.9e-05	0.0037	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	8.31e-05	0.00345	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SDHA—dilated cardiomyopathy	8.18e-05	0.0034	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	8.09e-05	0.00336	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	7.58e-05	0.00315	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ANKRD1—dilated cardiomyopathy	6.47e-05	0.00269	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	6.43e-05	0.00267	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	6.43e-05	0.00267	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—AGT—dilated cardiomyopathy	6.16e-05	0.00256	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—TAZ—dilated cardiomyopathy	6.08e-05	0.00253	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	5.98e-05	0.00249	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	5.84e-05	0.00243	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	5.84e-05	0.00243	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	5.79e-05	0.00241	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SDHA—dilated cardiomyopathy	5.5e-05	0.00228	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.43e-05	0.00226	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	5.26e-05	0.00219	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	5.2e-05	0.00216	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.99e-05	0.00207	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.86e-05	0.00202	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.69e-05	0.00195	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.38e-05	0.00182	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.26e-05	0.00177	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.89e-05	0.00162	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.64e-05	0.00151	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.48e-05	0.00145	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.45e-05	0.00143	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.45e-05	0.00143	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.35e-05	0.00139	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.31e-05	0.00138	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.27e-05	0.00136	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.21e-05	0.00133	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AGT—dilated cardiomyopathy	3.16e-05	0.00131	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.11e-05	0.00129	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.94e-05	0.00122	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.89e-05	0.0012	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.52e-05	0.00105	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GPX1—dilated cardiomyopathy	2.22e-05	0.000924	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.19e-05	0.000912	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CD36—dilated cardiomyopathy	2.16e-05	0.0009	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.16e-05	0.000899	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.07e-05	0.000859	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.95e-05	0.000812	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AGT—dilated cardiomyopathy	1.95e-05	0.00081	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.94e-05	0.000806	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AGT—dilated cardiomyopathy	1.87e-05	0.000776	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.5e-05	0.000625	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GPX1—dilated cardiomyopathy	1.49e-05	0.000621	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CD36—dilated cardiomyopathy	1.45e-05	0.000604	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AGT—dilated cardiomyopathy	1.31e-05	0.000544	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.3e-05	0.000539	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EGFR—dilated cardiomyopathy	8.89e-06	0.000369	CbGpPWpGaD
